Page last updated: 2024-08-24

tenofovir and combivent respimat

tenofovir has been researched along with combivent respimat in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kabwigu, S; Kamira, B; Kemigisha, D; Kiweewa Matovu, F; Mubiru, MC; Muwawu, R; Nakabiito, C; Nakyanzi, T; Wynne, J1

Trials

1 trial(s) available for tenofovir and combivent respimat

ArticleYear
Maximizing participant retention in a phase 2B HIV prevention trial in Kampala, Uganda: The MTN-003 (VOICE) Study.
    HIV clinical trials, 2018, Volume: 19, Issue:5

    Topics: Administration, Intravaginal; Administration, Oral; Adult; Albuterol, Ipratropium Drug Combination; Anti-HIV Agents; Clinical Trials as Topic; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; Gels; HIV Infections; Humans; Longitudinal Studies; Patient Participation; Tenofovir; Uganda

2018